Metabolism of antipyrine and m-xylene in rats after prolonged pretreatment with xylene alone or xylene with ethanol, phenobarbital or 3-methylcholanthrene

References

• Aitio A. A simple and sensitive assay of 7-ethoxycoumarin deethylation. Analytical Biochemistry 1978; 85: 488–491
   PubMed Web of Science ®Google Scholar
• Aitio A., Vainio H. UDP glucuronosyltranferase and mixed-function oxidase activity in microsomes prepared by differential centrifugation and calcium aggregation. Acta Pharmacologica et Toxicologica 1976; 39: 555–561
   PubMedGoogle Scholar
• Böttcher J., Bässmann H., Erxleben I., Schiebel H.-M. Identification of conjugated metabolites of antipyrine in urine by pyrolysis-electron-impact mass spectrometry. Journal of Analytical and Applied Pyrolysis 1984; 6: 1–18
   Google Scholar
• Böttcher J., Bässmann H., Schüppel R. Primary and secondary hydroxylation pattern of antipyrine in the isolated perfused rat liver preparation as affected by 3-MC. Cytochrome P-450, Biochemistry, Biophysics and Environmental Implications, E. Hietanen, E. M. Laitinen, O. Hänninen. Elsevier, Amsterdam 1982; 329–332
   Google Scholar
• Bradbury S. L., Clark F. J., Steinman C. R., Jakoby W. B. Aldehyde dehydrogenase from baker's yeast. Methods in Enzymology 1975; 41: 354–360
   PubMedGoogle Scholar
• Bray H. G., Humphris B. G., Thorpe W. V. Metabolism of derivatives of toluene. 3. o-, m- and p-xylenes. Biochemical Journal 1949; 45: 241–244
   Web of Science ®Google Scholar
• Bray H. G., Humphris B. G., Thorpe W. V. Metabolism of derivatives of toluene. 5. The fate of xylenols in the rabbit, with further observations on the metabolism of the xylenes. Biochemical Journal 1950; 47: 395–399
   PubMed Web of Science ®Google Scholar
• Breimer D. D. Interindividual variations in drug disposition. Clinical implications and methods of investigation. Clinical Pharmacokinetics 1983; 8: 371–377
   PubMed Web of Science ®Google Scholar
• Buppodom P., Koga N., Yamada H., Yoshimura H. Studies on rat cytochrome P-450s involved in the metabolism of antipyrine: phenobarbital- and 3-methylcholanthrene-inducible isoenzymes possessing 4-hydroxylase activity. Biochemical Pharmacology 1986; 35: 1404–1406
   PubMed Web of Science ®Google Scholar
• Crowley C., Gillham B., Thorn M. B. A direct enzymic method for the determination of reduced glutathione in blood and other tissues. Biochemical Medicine 1975; 13: 287–292
   PubMed Web of Science ®Google Scholar
• Danhof M., Teunissen M. W. E. Antipyrine as a model drug to assess oxidative drug metabolizing activity in man. Pharmacy International 1984; 5: 11–15
   Google Scholar
• Danhof M., Krom D. P., Breimer D. D. Studies on the different metabolic pathways of antipyrine in the rats: Influence of phenobarbital and methylcholanthrene treatment. Xenobiotica 1979; 9: 695–702
   PubMed Web of Science ®Google Scholar
• Danhof M., Teunissen M. W. E., Breimer D. D. A reconsideration of previously published data and synthesis of pure reference substance. Pharmacology 1982; 24: 181–184
   PubMed Web of Science ®Google Scholar
• van Doorn R., Bos R. P., Brouns R. M. E., Leijdekkers Ch.-M., Henderson P. Th. Effect of toluene and xylenes on liver glutathione and their urinary excretion as mercapturic acids in the rat. Archives of Toxicology 1980; 43: 293–304
   PubMed Web of Science ®Google Scholar
• Dössing M. Noninvasive assessment of microsomal enzyme activity in occupational medicine: Present state of knowledge and future perspectives. International Archives of Occupational and Environmental Health 1984; 53: 205–218
   PubMedGoogle Scholar
• Elovaara E. Dose-related effects of m-xylene inhalation on the xenobiotic metabolism of the rat. Xenobiotica 1982; 12: 345–352
   PubMed Web of Science ®Google Scholar
• Elovaara E., Collan Y., Pfäffli P., Vainio H. The combined toxicity of technical grade xylene and ethanol in the rat. Xenobiotica 1980; 10: 435–445
   PubMed Web of Science ®Google Scholar
• Elovaara E., Engström K., Vainio H. Metabolism and disposition of simultaneously inhaled m-xylene and ethylbenzene in the rat. Toxicology and Applied Pharmacology 1984; 75: 466–478
   PubMed Web of Science ®Google Scholar
• Elovaara E., Pfäffli P., Savolainen H., Vainio H. Marginal role of impaired aldehyde metabolism in m-xylene vapour-induced biochemical effects in the rat. Journal of Applied Toxicology 1982; 2: 27–32
   Google Scholar
• Elovaara E., Savolainen H., Parkki M. G., Aitio A., Vainio H. Neurochemical effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Wistar and Gunn rats. Research Communications in Chemical Pathology and Pharmacology 1977; 18: 487–494
   PubMedGoogle Scholar
• Elovaara E., Zitting A., Nickels J., Aitio A. m-Xylene inhalation destroys cytochrome P-450 in rat lung at low exposure. Archives of Toxicology 1987; 61: 21–26
   PubMed Web of Science ®Google Scholar
• Engström K., Riihimäki V. Method 11. Determination of methylhippuric acids in urine by gas chromatography. Environmental Carcinogens—Methods of Analysis and Exposure Measurement. International Agency for Research on Cancer Scientific Publications No. 85, 1988; Vol. 10: 313–318
   Google Scholar
• Gadeholt G., Aarbakke J., Dybing E., Sjöblom M., Mörland M. Hepatic microsomal drug metabolism, glutamyl transferase activity and in vivo antipyrine half-life in rats chronically fed an ethanol diet, a control diet and chow diet. Journal of Pharmacology and Experimental Therapeutics 1980; 213: 196–203
   Google Scholar
• Habig W. H., Babst M. J., Jakoby W. B. Glutathione S-transferases: the first enzymatic step in mercapturic acid formation. Journal of Biological Chemistry 1974; 249: 7130–7139
   PubMed Web of Science ®Google Scholar
• Hänninen O. On the metabolic regulation in the glucuronic acid pathway in the rat tissue. Annales Academiae Scienfiarum Fennieae, Series AII 1968; 142: 1–96
   Google Scholar
• Hood R. D., Ottley M. S. Developmental effects associated with exposure to xylene: a review. Drug and Chemical Toxicology 1985; 8: 281–297
   PubMed Web of Science ®Google Scholar
• Hukki J., Myry J. Synthesis of 4-antipyryl alkamine ethers. Acta Chemica Scandinavica 1959; 13: 174–177
   Google Scholar
• Inaba T., Lucassen M., Kalow W. Antipyrine metabolism in the rat by three hepatic monooxygenases. Life Sciences 1980; 26: 1977–1983
   PubMed Web of Science ®Google Scholar
• Johannesen K. A. M., DePierre J. W. Measurement of cytochrome P450 in the presence of large amounts of contaminating hemoglobin and methoglobin. Analytical Biochemistry 1978; 86: 725–732
   PubMed Web of Science ®Google Scholar
• Koike E., Iida H., Okauna M., Kashioka A. Organic pigments. II. Synthesis of 1-phenyl-3-methyl-5-pyrazolone and its derivatives. Journal of the Chemical Society of Japan 1954; 57: 56–58
   Google Scholar
• Kroos-De Haan M. A., Noordhoek J. Enhancement of antipyrine clearance and induction of antipyrine 4-hydroxylation by 3-methylcholanthrene. British Journal of Pharmacology 1980; 68: 120p
   Google Scholar
• Lowry O. H., Rosenbrough H. J., Farr A. L., Randall R. J. Protein measurement with Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Nakagawa A., Chiba K., Ishizaki T., Nakamura K. Influence of cigarette smoke on antipyrine metabolite formation in rats. Research Communications in Chemical Pathology and Pharmacology 1983; 41: 473–491
   Google Scholar
• Nakagawa A., Nakamura K., Maeda K., Kamataki T., Kato R. Studies on in vitro antipyrine metabolism by 13C, 15N double labeled method. Life Sciences 1987; 41: 133–143
   Google Scholar
• NIOSH (National Institute for Occupational Safety and Health). Criteria for a Recommended Standard…Occupational Exposure to Xylene. US Department of Health Education and Welfare, US Government Printing Office, Washington, DC 20402 1975; 1–101
   Google Scholar
• Norström Å., Andersson B., Levin J.-O. A procedure for the analysis of S-benzyl-N-acetylcysteine and S-(o-methylbenzyl)-N-acetylcysteine in human urine. Xenobiotica 1986; 16: 525–529
   PubMed Web of Science ®Google Scholar
• Ogata M., Fujii T. Urinary excretion of hippuric acid and m-methylhippuric acid after administration of toluene and m-xylene mixture to rats. International Archives of Occupational and Environmental Health 1979; 43: 45–51
   PubMedGoogle Scholar
• Omura T., Sato R. The carbon monoxide binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry 1964; 239: 2370–2378
   PubMed Web of Science ®Google Scholar
• Patel J. M., Harper C., Drew R. T. The biotransformation of p-xylene to a toxic aldehyde. Drug Metabolism and Disposition 1978; 6: 368–374
   PubMed Web of Science ®Google Scholar
• Patel J. M., Harper C., Gupta B. N., Drew R. T. Changes in serum enzymes after inhalation exposure of p-xylene. Bulletin of Environmental Contamination and Toxicology 1979; 21: 17–24
   PubMed Web of Science ®Google Scholar
• Philpot R. M., Smith B. R. Role of cytochrome P-450 and related enzymes in the pulmonary metabolism of xenobiotics. Environmental Health Perspectives 1984; 55: 359–367
   PubMed Web of Science ®Google Scholar
• Prough R. A., Burke M. D., Mayer R. T. Direct fluoromethric methods for measuring mixed-function oxidase activity. Methods of Enzymology 1978; 52(part C)372–377
   Google Scholar
• Pyykkö K. Effects of methylbenzenes on microsomal enzymes in rat liver, kidney and lung. Biochimica et Biophysica Acta 1980; 633: 1–9
   PubMed Web of Science ®Google Scholar
• Pyykkö K. Characterization of stability of rat liver microsomes isolated by rapid gel filtration method. Acta Pharmacologica et Toxicologica 1983; 52: 39–46, Recommended Methods for the Determination of Four Enzymes in Blood, (1974). Scandinavian Journal of Clinical Laboratory Investigations, 33, 291–306
   PubMedGoogle Scholar
• Rhodes J. C., Houston J. B. Antipyrine metabolite kinetics in phenobarbital and β- naphthoflavone-induced rats. Drug Metabolism and Disposition 1983; 11: 131–136
   PubMed Web of Science ®Google Scholar
• Riihimäki V. Xylene. Biological Monitoring and Surveillance of Workers Exposed to Chemicals, A. Aitio, V. Riihimäki, H. Vainio. Hemisphere, London 1984; 83–97
   Google Scholar
• Riihimäki V., Pfäffli P., Savolainen K., Pekari K. Kinetics of m-xylene in man. Scandinavian Journal of Work, Environment & Health 1979; 5: 217–231
   PubMed Web of Science ®Google Scholar
• Saville B. A scheme for the colorimetric determination of microgram amounts of thiols. Analyst 1958; 83: 670–672
   Web of Science ®Google Scholar
• Savolainen H., Vainio H., Helojoki M., Elovaara E. Biochemical and toxicological effects of short-term intermittent xylene inhalation exposure and combined ethanol intake. Archives of Toxicology 1978; 41: 195–205
   PubMed Web of Science ®Google Scholar
• Sedivec V., Flek J. The absorption, metabolism and excretion of xylenes in man. International Archives of Occupational and Environmental Health 1976; 37: 205–217
   PubMed Web of Science ®Google Scholar
• Shaw P. N., Houston J. B. Temporal effects on antipyrene metabolite kinetics in Arochlor 1254-treated rats. Toxicology and Applied Pharmacology 1986; 84: 232–240
   Google Scholar
• Slusher L. B., Park S. S., Gelboin H. V., Vesell E. S. Studies on the metabolism of aminopyrine, antipyrine and theophylline using monoclonal antibodies to cytochrome P-450 isozymes purified from rat liver. Biochemcial Pharmacology 1987; 36: 2359–2367
   PubMed Web of Science ®Google Scholar
• Smith B. R., Bend J. R. Metabolic interactions of hydrocarbons with mammalian lung. Reviews in Biochemical Toxicology, E. Hodgson, J. R. Bend, R. M. Philpot. Elsevier North-Holland, Amsterdam 1981; Vol. 3: 77–122
   Google Scholar
• Smith B. R., Plummer J. L., Wolf C. R., Philpot R. M., Bend J. R. p-Xylene metabolism by rabbit lung and liver and its relationship to the selective destructive of pulmonary cytochrome P-450. Journal of Pharmacology and Experimental Therapeutics 1982; 223: 736–742
   PubMed Web of Science ®Google Scholar
• Teunissen M. W. E., Van Graft M., Vermeulen N. P. E., Breimer D. D. Influence of allylisopropylacetamine and phenobarbital treatment on in vivo antipyrine metabolite formation in rats. Xenobiotica 1983a; 13: 497–502
   PubMed Web of Science ®Google Scholar
• Teunissen M. W. E., Joeres R. P., Vermeulen N. P. E., Breimer D. D. Influence of 9-hydroxyellipticine and 3-methylcholanthrene formation on antipyrine metabolite formation in rats in vivo. Xenobiotica 1983b; 13: 223–231
   PubMed Web of Science ®Google Scholar
• Teunissen M. W. E., Meerburg-Van der Torren J. E., Vermeulen N. P. E., Breimer D. D. Automated high-performance liquid chromatographic determination of antipyrene and its main metabolites in plasma, saliva and urine, including 4,4′-dihydroxyantipyrine. Journal of Chromatography (Biomed. Appl.) 1983c; 278: 367–378
   PubMed Web of Science ®Google Scholar
• Toftgård R. Effects of xylene exposure on the metabolism of antipyrine in vitro and in vivo in the rat. Toxicology 1983; 28: 117–131
   PubMed Web of Science ®Google Scholar
• Toftgård R., Halpert J., Gustafsson J.-Å. Xylene induces a cytochrome P-450 isozyme in rat liver similar to the major isozyme induced by phenobarbital. Molecular Pharmacology 1983; 23: 265–271
   PubMed Web of Science ®Google Scholar
• Toftgård R., Nilsen O. G. Effects of xylene and xylene isomers on cytochrome P-450 and in vitro enzymatic activities in rat liver, kidney and lung. Toxicology 1982; 23: 197–212
   PubMed Web of Science ®Google Scholar
• Uotila L., Koivusalo M. Formaldehyde dehydrogenase. Methods of Enzymology 1981; 77: 314–320
   PubMedGoogle Scholar
• Vesell E. S. The antipyrine test in clinical pharmacology: conceptions and misconceptions. Clinical Pharmacology and Therapeutics 1979; 26: 275–286
   PubMed Web of Science ®Google Scholar
• Vesell E. S. Complex, dynamically interacting host factors that affect the disposition of drugs and carcinogens. Host Factors in Human Carcinogenesis, H. Bartsch, B. Armstrong, W. Davis. International Agency for Research on Cancer (IARC) Scientific Publications No. 39, IARC, LyonFrance 1982; 427–437
   Google Scholar
• Vesell E. S., Penno M. B. Assessment of methods to identify sources of interindividual pharmacokinetic variations. Clinical Pharmacokinetics 1983; 8: 378–409
   PubMed Web of Science ®Google Scholar
• White S. M., Allen J. G., Altman J. F. B. The effect of midazolam administration on the pharmacokinetics of antipyrine in the rat. Xenobiotica 1987; 17: 869–873
   PubMed Web of Science ®Google Scholar
• WHO (World Health Organization). Recommended health-based limits in occupational exposure to selected organic solvents: xylene. WHO Technical Report Series 664, WHO, Geneva 1981; 25–37
   Google Scholar
• Yoshihara S., Nagata K., Yoshimura H. Different responsiveness of hepatic and pulmonary microsomal mixed function oxidases to phenobarbital and 3-methylcholanthrene-type polychlorinated biphenyls in rats. Journal of Pharmacobio-Dynamics 1983; 6: 954–962
   PubMedGoogle Scholar